Abraham Yale
Foot & Ankle Surgery · Fairfield, CTNPI 1063511210
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $374 and has fallen 93.1% since, to $26 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in CT, where the typical reported total is $1,838.
Across 68 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sebela Pharmaceuticals Inc.$295
- Smith+Nephew$213
- Melinta Therapeutics, LLC$140
- Paratek Pharmaceuticals, Inc.$101
- Medtronic$97
- Stryker$72
- plus $392 from 11 others
What the payments were for
- Food & beverage$1,308100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sebela Pharmaceuticals Inc. | 22 | $295 |
| Smith+Nephew | 12 | $213 |
| Melinta Therapeutics, LLC | 2 | $140 |
| Paratek Pharmaceuticals, Inc. | 5 | $101 |
| Medtronic(2 entities) | 5 | $97 |
| Stryker | 2 | $72 |
| Amgen | 4 | $65 |
| Merck | 3 | $56 |
| Nabriva Therapeutics, PLC | 3 | $50 |
| Zimvie Inc. | 1 | $43 |
| Tactile Systems Technology Inc | 2 | $34 |
| Bioventus LLC | 2 | $32 |
| Highridge Medical LLC | 1 | $29 |
| Lifenet Health | 1 | $26 |
| Reprise Biomedical, Inc. | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $19 |
| GRT US Holding, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Baxdela$125
How this compares
$1,308 in reported general payments places this provider in the 40th percentile of 89 foot & ankle surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 20 | $500 |
| Mupirocin | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Fairfield
- William ProbascoFairfield$26K
- Jeffrey BestFairfield$5K
- Thomas McDonaldEnfield$241K
- Jossie AbrahamNorwalk$152K
- Gabriel GambardellaBloomfield$99K
- David CaminearHamden$47K
- James DejesusNaugatuck$40K
- Adebola AdelekeMiddletown$24K
- Rachel AlbrightDarien$14K
- Paulina PiekarskaNorwalk$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.